ReviewBMC ophthalmology2022
Is dry eye disease the same in young and old patients? A narrative review of the literature.
Review in BMC ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 46 citations in OpenAlex.
- Effect of Bioptron light therapy on dryness of eyes in postmenopausal women: a randomized controlled trial.Lasers in medical science · 2026Trial
- Ambient air pollutants and outpatient visits for conjunctivitis in Hefei, China: a time-series study of hospital-based data during 2014-2023.Frontiers in public health · 2026Article
- Epidemiological study of dry eye disease in Gansu Province based on mathematical modeling: analysis of regional population characteristics and identification of risk factors.Frontiers in public health · 2026Article
- Review
- Pregnancy and Dry Eye Syndrome: A Review for Clinical Practice.International journal of molecular sciences · 2025Review
- Comparison of SPEED and OSDI questionnaires for dry eye symptom in Chinese college students: a cross-sectional study.BMC ophthalmology · 2025Article
- Emerging Age-Specific Therapeutic Approaches for Dry Eye Disease.Journal of clinical medicine · 2025Review
- New Insights into the Role of Cellular Senescence and Its Therapeutic Implications in Ocular Diseases.Bioengineering (Basel, Switzerland) · 2025Review
- Development andNanoscale advances · 2025Article
- The Duration of Cataract Surgery and the Change in Postoperative Dry Eye Disease Parameters: A Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2025Article
- To assess the effectiveness of Systane COMPLETE in improving meibomian gland score and in reducing symptoms of ocular dryness.Frontiers in ophthalmology · 2025Article
- Relationship between tear film stability, dry eye symptoms, and night driving vision among Malaysian adults.PloS one · 2025Article
- Microplastics and nanoplastics in the ocular environment: Pathways, toxic effects, and future challenges.Current research in toxicology · 2025Review
- Relationship between dry eye disease and myopia: A systematic review and meta-analysis.Heliyon · 2024Article
- The role of oxidative stress in the pathogenesis of ocular diseases: an overview.Molecular biology reports · 2024Review
- Consumption ofInternational journal of molecular sciences · 2024Article
- Managing Dry Eye Disease with Novel Medications: Mechanism, Study Validity, Safety, Efficacy, and Practical Application.Pharmacy (Basel, Switzerland) · 2024Review
- Dry Eye and Some Related Factors in Patients with Type 2 Diabetic Nephropathy: A Cross-Sectional Study in Vietnam.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Effects of social support on vision-related quality of life in older adults with dry eye disease: the chain mediating role of illness perception and coping style.Frontiers in psychology · 2024Article
- Dry eye rate and its relationship with disease stage in patients with primary hypertension: a cross-sectional study in Vietnam.International journal of ophthalmology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced age is one of the most evident risk factors for dry eye disease (DED), with male/female sex, chronic drug consumption, and prolonged device use. This article aims to review the literature about the changes of the ocular surface associated with DED in the elderly and patients < 40 years. The pathophysiologic changes of the ocular surface responsible for eye dryness are linked with inflammation and neurosensory abnormalities and may occur with a different feature in young patients compared with elders. Peculiar treatment strategies may be needed for young and older subjects with DED.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.